Rezolute Inc. Common Stock (NV) (RZLT)
Stock · NASDAQ · Health Care
$4.63as of 8/28/2026
Price chart
Open in TradingViewAbout RZLT
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypogl…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 68
- Website
- www.rezolutebio.com
Fundamentals
- 1-day range
- $4.44$4.75
- Market cap
- $452.57M
- P/E (trailing)
- —
- P/E (forward)
- -7.35
- EPS (trailing)
- $-0.81
- Dividend yield
- —
- Beta
- 0.62
- Avg. volume
- 1.81M
- Dividend pay date
- October 13, 2020
Forecasts
9 analyst ratings
Rezolute Inc. Common Stock (NV) Competitors
Chosen by industry and closest market cap.
- RZLTRezolute Inc. Common Stock (NV)$4.62▼ 7.23%Market cap $452.57MP/E —$1.07$11.46
- BNTCBenitec Biopharma Inc. Common Stock$12.51▼ 1.30%Market cap $451.07MP/E —$9.85$16.76
- PRTAProthena Corporation plc Ordinary Shares$9.35▲ 2.86%Market cap $449.19MP/E —$7.73$11.8
- LRMRLarimar Therapeutics Inc. Common Stock$4▼ 1.23%Market cap $436.31MP/E —$2.72$6.42
- QTTBQ32 Bio Inc. Common Stock$15.01▼ 7.06%Market cap $482.18MP/E 15.71$1.62$23.57
- EOLSEvolus Inc. Common Stock$8.89▲ 0.06%Market cap $487.98MP/E —$3.86$9.12
- AQSTAquestive Therapeutics Inc. Common Stock$5.02▼ 2.71%Market cap $491.83MP/E —
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| RZLT Rezolute Inc. Common Stock (NV) | $452.57M | — | $4.62 | ▼ 7.23% | $1.07$11.46 |
| BNTC Benitec Biopharma Inc. Common Stock | $451.07M | — | $12.51 | ▼ 1.30% | $9.85$16.76 |
| PRTA Prothena Corporation plc Ordinary Shares | $449.19M | — | $9.35 | ▲ 2.86% | $7.73$11.8 |
| LRMR Larimar Therapeutics Inc. Common Stock | $436.31M | — | $4 | ▼ 1.23% | $2.72$6.42 |
| QTTB Q32 Bio Inc. Common Stock | $482.18M | 15.71 | $15.01 | ▼ 7.06% | $1.62$23.57 |
| EOLS Evolus Inc. Common Stock | $487.98M | — | $8.89 | ▲ 0.06% | $3.86$9.12 |
| AQST Aquestive Therapeutics Inc. Common Stock | $491.83M | — | $5.02 | ▼ 2.71% |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →- Brian Kenneth Roberts · July 2, 2026 · Tax Withholding3.1K @ $4.99
- Daron Evans · July 2, 2026 · Tax Withholding3.1K @ $4.99
- Nevan C. Elam · July 2, 2026 · Tax Withholding8.0K @ $4.99
- Daron Evans · March 30, 2026 · Buy10.0K @ $2.85
- Brian Kenneth Roberts · March 2, 2026 · Tax Withholding11.4K @ $2.99
- Daron Evans · March 2, 2026 · Tax Withholding11.4K @ $2.99
- Nevan C. Elam · March 2, 2026 · Tax Withholding27.6K @ $2.99
Institutional Ownership
March 31, 2026
- Total shares held
- 83.96M
- Total value held
- $254.91M
- Institutional holders
- 122
- Unknown12.99M
- Unknown9.18M
- Unknown6.31M
- Unknown6.30M
- Unknown5.05M
- Unknown3.52M
- Unknown3.44M
- Unknown3.33M
- Unknown2.97M
- Unknown2.75M
See the full, filterable feed with live charts on the MarketWall dashboard.